We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
9 hedge funds and large institutions have $2.72M invested in Windtree Therapeutics in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more funds holding
Funds holding: 6 → 9 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
18% less capital invested
Capital invested by funds: $3.33M → $2.72M (-$616K)
Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
2
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$2.31M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.3M |
| 2 |
KC
Kepos Capital
New York
|
+$433K |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$216K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$216K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$216K |
